113 results
8-K
EX-4.2
ATXI
Avenue Therapeutics Inc
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
8-K
EX-4.1
ATXI
Avenue Therapeutics Inc
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
8-K
EX-10.2
ATXI
Avenue Therapeutics Inc
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
) shares of Common Stock to deliver in satisfaction of a sale by the Holder of all or any portion of the number of shares of Common Stock, or a sale
8-K
EX-10.1
m70 p3ftptg6f7hqjeq
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-99.1
572ves68mtt6d d3p
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
r6edd5mpu
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.1
iu86lti0jezwyhhpmwqt
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.2
gstq wttp
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.1
l6q skvo3ulkqxmdbw2
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.4
mp4sz 8qte
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-99.1
0uzlbte
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-10.2
bi4mzhu07zt6iketk4e9
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
8-K
EX-4.3
y8zd1
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
424B4
086eky
2 Nov 23
Prospectus supplement with pricing info
9:00am